Back to Journals » ClinicoEconomics and Outcomes Research » Volume 9

Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis

Total article views   HTML views PDF downloads Totals
14,971 Dovepress* 13,825+ 1,906 15,731
PubMed Central* 1,146 229 1,375
Totals 14,971 2,135 17,106
*Since 10 January 2017
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 0 3

View citations on PubMed and Google Scholar